Blocking blue light during mania - markedly increased regularity of sleep and rapid improvement of symptoms: A case report

Bipolar Disorders

Volumn 16, Issue 8, 2014, Pages 894-898

  Henriksen, Tone Eg ^a,b,c   Skrede, Silje ^a,c   Fasmer, Ole Bernt ^a,c   Hamre, Børge ^a   Grønli, Janne ^a,c   Lund, Anders ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b Norway and MoodNet Research Group   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Actigraphy; Blue blockers; Case report; Mania; Sleep; Virtual darkness

Indexed keywords

CARBAMAZEPINE; DIAZEPAM; HALOPERIDOL; LITHIUM SALT; OLANZAPINE;

ACTIMETRY; ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ARTICLE; BIPOLAR I DISORDER; BIPOLAR MANIA; BLUE LIGHT; BLUE LIGHT BLOCKING GLASSES; CASE REPORT; CAUCASIAN; DISEASE DURATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; DSM-IV-TR; HOSPITALIZATION; HUMAN; LIGHT EXPOSURE; MALE; MIDDLE AGED; MOTOR ACTIVITY; PATIENT MONITORING; PHYSICAL MEDICINE; PRIORITY JOURNAL; SLEEP PATTERN; SPECTACLES; VIRTUAL DARKNESS THERAPY; WAKEFULNESS; YOUNG MANIA RATING SCALE;

EID: 84913610021     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12265     Document Type: Article

References (18)

1. Coryell W, Keller M, Lavori P, Endicott J. Affective syndromes, psychotic features, and prognosis: II. Mania. Arch Gen Psychiatry 1990; 47: 658-662.
2. Harvey A. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 2008; 165: 820-829.
3. Bauer M, Glenn T, Alda M et al. Impact of sunlight on the age of onset of bipolar disorder. Bipolar Disord 2012; 14: 654-663.
4. Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E. Treatment of a rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry 1998; 43: 822-828.
5. Wirz-Justice A, Quinto C, Cajochen C, Werth E, Hock C. A rapid-cycling bipolar patient treated with long nights, bedrest, and light. Biol Psychiatry 1999; 45: 1075-1077.
6. Barbini B, Benedetti F, Colombo C et al. Dark therapy for mania: a pilot study. Bipolar Disord 2005; 7: 98-101.
7. Brainard GC, Hanifin JP, Greeson JM et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 2001; 21: 6405-6412.
8. Berson DM. Phototransduction in ganglion-cell photoreceptors. Pflügers Arch 2007; 454: 849-855.
9. Revell VL, Arendt J, Fogg LF, Skene DJ. Alerting effects of light are sensitive to very short wavelengths. Neurosci Lett 2006; 399: 96-100.
10. Vandewalle G, Maquet P, Dijk D-J. Light as a modulator of cognitive brain function. Trends Cogn Sci 2009; 13: 429-438.
11. Benarroch EE. The melanopsin system: phototransduction, projections, functions, and clinical implications. Neurology 2011; 76: 1422-1427.
12. Sasseville A, Paquet N, Sévigny J, Hébert M. Blue blocker glasses impede the capacity of bright light to suppress melatonin production. J Pineal Res 2006; 41: 73-78.
13. Kayumov L, Casper RF, Hawa RJ et al. Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work. J Clin Endocrinol Metab 2005; 90: 2755-2761.
14. van de Werken M, Giménez MC, de Vries B, Beersma DG, Gordijn MC. Short-wavelength attenuated polychromatic white light during work at night: limited melatonin suppression without substantial decline of alertness. Chronobiol Int 2013; 30: 843-854.
15. Phelps J. Dark therapy for bipolar disorder using amber lenses for blue light blockade. Med Hypotheses 2008; 70: 224-229.
16. Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
17. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Alterations to plasma melatonin and cortisol after evening alprazolam administration in humans. Chronobiol Int 1993; 10: 205-213.
18. Monteleone P, Forziati D, Orazzo C, Maj M. Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans. J Pineal Res 1989; 6: 253-258.